Category

ODAC

ODAC 2021 | REVIEW OF A VIRTUAL EVENT

By | ODAC

NEW YORK, (January 22, 2021) –  Shelley Tanner, SanovaWorks CEO/President

ODAC Dermatology, Aesthetic and Surgical Conference 2021 – Virtual

At the start of 2020 SanovaWorks and the ODAC Team produced our annual conference in Orlando. This yearly event is a highlight on the dermatology community calendar. As 2020 started to reveal itself, it became clear we would not be able to produce a live event in 2021. For the best interests and the health of our staff, faculty, sponsors, and attendees we made the decision to offer a live virtual event with on-demand access to all sessions with registration.

ODAC Virtual 2021

I would like to personally thank the team that made this all happen. Because of your expertise and hard work, all the marketing, tech support, administrative coordination, and more–paid off. As a result, ODAC 2021 Virtual was one of the most successful ODAC conferences to-date.

Additionally, I want to recognize our faculty, speakers, and sponsorsYour willingness to share your time and expertise was critical to the success of this year’s conference and we hope you have enjoyed being part of it. We are thrilled at the prospect of having you all join us again next year for ODAC 2022–live, in-person, once again.

We are extremely proud of what we have accomplished together, which includes:

  • Nearly 2,000 people tuned in to ODAC  (950+ on the app and an additional 1,000 via workshops)
  • 90% MD/DO Attendees
  • Over 300 ARTE Scholars and residents
  • 20 Sponsor and Exhibiting companies
  • 21 hours of CME
  • ODAC Sneak Peek Inflammatory Diseases Symposium
  • 9 Virtual Solution Rooms
  • 4 CME workshops 
  • 7 sponsored sessions with an average of 200 attendees, peaking at 850 attendees
  • Five-day Board Review Week with 700 residents in attendance
  • 1 million attendee engagements in the event app 
  • 500,000+ minutes of content watched

ABOUT ODAC

ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century. Founded in 2003 by dermatology pioneer, Dr. Perry Robins, the ODAC Dermatology Conference provides nearly 700 dermatologists, residents, nurse practitioners, and physician assistants with important annual updates and fresh practical pearls in the field of medical, cosmetic, and surgical dermatology in a highly interactive format.

Dermatologists attend ODAC to stay informed and up-to-date on clinical dermatology updates, new treatments, new uses for old treatments, new product lines, changes to therapeutic guidelines and to witness live demonstrations from the experts. Unique to ODAC, each presentation focuses on practical pearls you can immediately use in your practice.

Attendees of the ODAC Dermatology Conference

  • Discuss the next generation of diagnostic approaches and evidence-based dermatology treatments
  • Observe cutting-edge procedures and techniques with live demonstrations of novel products and emerging technologies
  • Review clinical trial results and discuss case-studies in both large and small group settings
  • Cultivate relationships with colleagues and leaders actively shaping the future of dermatology
  • Earn CME – up to 31 AMA PRA Category 1 Credits™

ODAC recognizes that you hold the vision, highly specialized expertise, and unique training that drives dermatology. ODAC is organized and produced by SanovaWorks.

THANK YOU ODAC SPONSORS

By | ODAC

NEW YORK, (January 13, 2021) – Luciana Halliday Nofal, VP Marketing and Client Relations SanovaWorks

ODAC Dermatology Aesthetic and Surgical conference 

This year, due to the global pandemic, SanovaWorks is hosting ODAC Dermatology, Aesthetic and Surgical conference, virtually. ODAC is committed to providing high-quality education in an engaging virtual format with top speakers and important topics.

With nearly 1,000 US attendees registered, ODAC will provide a unique virtual experience that will continue to drive dermatology education and networking forward.

We appreciate all the effort that it takes to change direction and to make such an important and impactful event happen. We are deeply grateful to our sponsors, faculty and attendees.

Please take a moment to acknowledge and thank our gracious supporters by visiting their sponsor page in ODAC Virtual app.

Platinum and Featured Sponsors  

Amgen logo

Please see the resources below to discover our data and explore our resources in our sponsor page.

 

Cassiopea, Inc. is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions such as acne, androgenetic alopecia and genital warts. Learn more about our company at www.cassiopea.com.

Our commitment to dermatology is built around a senior leadership team with deep roots and experience in the specialty. The management team is focused on providing unique treatment options, and to drive continued research and development in Dermatology, moving us to the forefront of the U.S. market.

We are excited to support dermatology healthcare professionals by contributing to the ODAC 2021 Conference.

Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com/us.

 

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity. Our research and development efforts in Dermatology are focused on a number of immune-mediated dermatologic conditions with a high unmet medical need, including atopic dermatitis, vitiligo, and hidradenitis suppurativa.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For more information, visit Incyte.com and follow @Incyte.

Visit the Incyte Dermatology Virtual Booth.

 

Neutrogena Logo

At Aveeno®, groundbreaking science transforms nature’s ingredients into clinically proven products that help soothe, strengthen, and restore the moisture barrier. Our oat, soy, and feverfew ingredients—derived from nature and uniquely formulated to optimize skin health and beauty—are supported by 75 years of published data, demonstrating the scientific rigor behind every result. Visit AveenoMD.com to learn about our new products, plus access clinical resources, patient resources, and product samples.

The #1 dermatologist recommended skincare brand continually elevates the science of skincare, delivering new products and innovations that support your treatment guidance. Visit NeutrogenaMD.com to learn what’s new, plus access clinical resources, patient resources, and product samples. NeutrogenaMD.com – dedicated to dermatology professionals.

 

La Roche-Posay logo

Our brands are dedicated to dermatology with offerings in professional skincare and cosmetics. Each brand is created by dermatologists or works in partnership with dermatologists to meet the health and safety standards for patients. Please visit the L’Oréal booth.

 

Novartis logo

Novartis is a leading global medicines company, using innovative science and digital technologies to create treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at www.novartis.com.

We hope you will take a moment to visit the COSENTYX® (secukinumab) Virtual Booth Experience to learn more about the Complete Cosentyx Approach.

 

Ortho Dermatologics is a specialty pharmaceutical business with the number one prescribed acne franchise and a portfolio of dermatology treatments in additional therapeutic areas including atopic dermatitis, fungal infections and psoriasis. Led by a team with deep experience in dermatology, we are dedicated to building meaningful connections with healthcare providers and their patients. Our ongoing commitment to the dermatology community shows through our pipeline of novel compounds and focused philanthropic activity here and around the globe.

 

Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe.

Please click the link below to visit our virtual booth!
https://www.dupixenthcp.com/virtualcongress

 

At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we how we live. It is our culture of care, embodied by our patient value strategy. That’s because how we do business – from discovery to development to delivery – has been transformed and redesigned around the patient and their individual experience. Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, more impactful solutions are on the horizon.

With a team of approximately 7,500 employees and operations in nearly 40 countries, we are a global biopharmaceutical company investing more than a quarter of our revenue in cutting-edge scientific research to meet unmet patient needs. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. UCB sites include global clinical development in Raleigh, North Carolina, research supporting UCB’s pipeline in Boston, Massachusetts (Bedford and Cambridge), Seattle, Washington, and Durham, North Carolina as part of our acquisition of Element Genomics, as well as an office in Washington, D.C.

CLICK to ENTER Virtual Experience

 

Official Media Partners

Friedman Dermatologist ODAC disaster preparedness

ODAC AND JDD HELP IDENTIFY NEED FOR DISASTER TRAINING AMONG DERMATOLOGISTS

By | ODAC, Press

A new study from the George Washington University found that many dermatologists are unprepared to respond to biological disasters and that the specialty would benefit from formal preparedness training.

WASHINGTON (Jan. 30, 2020) — The dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program, according to a study from the George Washington University (GW). The article is published in the Journal of Drugs in Dermatology.

Natural and man-made disasters can cause a range of dermatologic conditions due to environmental exposures, such as secondary infections following a flood, irritation from blistering agents used in chemical warfare, and acute and chronic effects of cutaneous radiation syndrome. A 2003 survey revealed that 88% of dermatologists felt unprepared to respond to a biological attack — this new survey shows that the need for training still exists.

“Recognizing and diagnosing the conditions that can arise following a disaster requires diagnostic acumen, knowledge on reporting, and short- and long-term management strategies,” said Adam Friedman, MD, interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences and senior author on the study.

This current survey from an interdisciplinary team of dermatology and emergency medicine researchers, led by Emily Murphy, a research fellow in the GW Department of Dermatology, examines whether the field of dermatology has advanced in its bioterrorism preparedness.

The survey, disseminated via the ODAC Dermatology, Aesthetic & Surgical conference listserv, found that only 28.9% of respondents received training in disaster preparedness and response. The respondents to the survey frequently commented that they felt dermatologists should be prepared for bioterrorism-related cutaneous diseases, such as anthrax or smallpox-related diseases, as well as infections resulting from natural disasters.

Similar to the 2003 survey, the authors found that few dermatologists received adequate bioterrorism preparedness training. Even among those who had reported training, many indicated they felt ill prepared to manage patients affected by disasters, especially biological attacks and nuclear or radiological events.

“While few respondents to the survey were trained in disaster preparedness, it is encouraging that 75% reported that it should be included in dermatology training,” Friedman said. “It is a necessary tool to advance the field.”

James Phillips, MD, section chief of disaster and operational medicine in the GW Department of Emergency Medicine, director of the GW Disaster Medicine Fellowship, and co-author on the study, agreed: “My fellows and I found great value in partnering with our dermatology colleagues for this project. It is my firm belief that, while disaster medicine and emergency management primarily fall within the scope of emergency medicine and trauma surgery, education, and training for other specialties is of great value and is virtually unexplored. In an increasingly complex disaster environment, we welcome such research collaborations with other GW specialists.”

###

The article, titled “A Survey of Dermatologists’ Preparedness for Natural and Man-made Disasters,” is published in the Journal of Drugs in Dermatology and can be found at jddonline.com/articles/dermatology/S1545961620P0016X/1.

ODAC DERMATOLOGY AESTHETIC & SURGICAL CONFERENCE 2020

By | A Note from Shelley, ODAC

NEW YORK (Jan. 28, 2020) – A Note from Shelley Tanner, SanovaWorks CEO/President

The SanovaWorks team was at our usual mid January event, The ODAC Dermatology, Aesthetic & Surgical Conference held January 17-20 in Orlando, Florida.

This year we celebrated a sold out conference with over 850 attendees that included US dermatologists, ARTE Scholar residents, dermatology nurse practitioners/physician assistants and industry leaders. The 11 breakout sessions, 12 sponsored sessions,10 live demonstrations, 10 roundtable sessions, and industry supported sessions, each with over 75 attendees and a brand new, 4-hour pre-conference aesthetic workshop with Dr. Shino Bay Aguilera were filled. 

A successful Monday program for 100+ dermatology residents and young dermatologists with hands-on injection training a young dermatology leader and mentorship program that offered seven dermatology residents the opportunity to connect one-on-one with leaders in the various areas of dermatology. 

Outstanding Educator & Mentor in Dermatology Award

The ODAC Dermatology, Aesthetic & Surgical Conference, in partnership with the Journal of Drugs in Dermatology (JDD), honored dermatologist Susan H. Weinkle, MD, with the Outstanding Educator & Mentor in Dermatology Award at the conference. 

It is a pleasure and an honor to recognize the tireless work of exceptional leaders in Dermatology, not only do these dermatology leaders dedicate their entire lives to benefiting patients every day, but after the “work day” ends, they spend countless hours involved in activities to improve the specialty’s future. We congratulate Dr. Weinkle for being chosen for this award. The award recognizes individuals who have demonstrated a long-standing commitment to educating and mentoring the next generation of dermatologists, and who have devoted a major portion of his or her professional life to enhancing the practice and profession of dermatology through education.

“Physicians around the globe have learned so much from Dr. Susan Weinkle,” said dermatologist and ODAC vice conference chair Joel Cohen, MD. “Susan has given all of us in aesthetics so much of her time and energy, and I am honored to present this award to her.”

More About Susan H. Weinkle, MD

Dr. Weinkle is an assistant clinical professor of dermatology at the University of South Florida, Tampa, Florida. She is a past president of the Women’s Dermatological Society and the American Society for Dermatologic Surgery. In addition, Dr. Weinkle is a former committee chair and member of the board of directors of several dermatology organizations, including the American Academy of Dermatology, Dermatology Foundation, and Florida Society of Dermatology and Dermatologic Surgery. Dr. Weinkle is in private practice in Bradenton, Fla., specializing in Mohs Micrographic Surgery and cosmetic dermatology. Her daughter, Allison, will join the practice upon completion of her dermatology residency and fellowships in cosmetic dermatology and Mohs Micrographic Surgery.

The recipient of the Outstanding Educator & Mentor in Dermatology Award, given by the Journal of Drugs in Dermatology, is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology practitioners and several industry leaders.

About the JDD

The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE ® /PubMed ® , was founded by dermatologist Perry Robins, MD. Now in its 19th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology, which provide readers with peer-reviewed content of the utmost quality. JDD is available complimentary to US dermatologists, residents, nurse practitioners and physician assistants.  Sign up at JDDonline.com

When the SanovaWorks team is in the ODAC zone and we are producing this conference and presenting awards for exceptional work, it is all worth that extra effort and push we give. I want to thank my team, the physicians, exhibitors and everyone who made ODAC 2020 a success.

Planning for ODAC January 15 – 18,  2021 is underway and I look forward to another successful and (SOLD OUT!) conference. Join us as an attendee or supporter.  

Cheers!

Shelley

Shelley Tanner, President CEO SanovaWorks

Susan Weinkle ODAC Award

ODAC VICE CHAIR SUSAN WEINKLE, MD RECOGNIZED AS OUTSTANDING EDUCATOR & MENTOR

By | ODAC, Press

ORLANDO, Fla. (Jan. 21, 2020) – The ODAC Dermatology, Aesthetic & Surgical Conference, in partnership with the Journal of Drugs in Dermatology (JDD), honored dermatologist Susan H. Weinkle, MD, with the Outstanding Educator & Mentor in Dermatology Award at the conference held January 17-20 in Orlando, Fla.

The award recognizes individuals who have demonstrated a long-standing commitment to educating and mentoring the next generation of dermatologists, and who have devoted a major portion of his or her professional life to enhancing the practice and profession of dermatology through education.

“It is a pleasure and an honor to recognize the tireless work of exceptional leaders in dermatology,” said Shelley Tanner, CEO and president of SanovaWorks, which produces the JDD, ODAC, Derm In-Review and Next Steps in Dermatology. “Not only do these dermatology leaders dedicate their entire lives to benefiting patients every day, but after the “work day” ends, they spend countless hours involved in activities to improve the specialty’s future. We congratulate Dr. Weinkle for being chosen for this award.”

“Physicians around the globe have learned so much from Dr. Susan Weinkle,” said dermatologist and ODAC vice conference chair Joel Cohen, MD. “Susan has given all of us in aesthetics so much of her time and energy, and I am honored to present this award to her.”

Dr. Weinkle is an assistant clinical professor of dermatology at the University of South Florida, Tampa, Fla. She is a past president of the Women’s Dermatological Society and the American Society for Dermatologic Surgery. In addition, Dr. Weinkle is a former committee chair and member of the board of directors of several dermatology organizations, including the American Academy of Dermatology, Dermatology Foundation, and Florida Society of Dermatology and Dermatologic Surgery. Dr. Weinkle is in private practice in Bradenton, Fla., specializing in Mohs Micrographic Surgery and cosmetic dermatology. Her daughter, Allison, will join the practice upon completion of her dermatology residency and fellowships in cosmetic dermatology and Mohs Micrographic Surgery.

The recipient of the Outstanding Educator & Mentor in Dermatology Award, given by the Journal of Drugs in Dermatology, is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology practitioners and several industry leaders.

 

MOC CertLink ODAC Dermatology

DR. STRATMAN TO PRESENT MOC CERTLINK AT ODAC

By | ODAC

NEW YORK (Oct. 30, 2019) – Erik J. Stratman, MD, 2019 President of the American Board of Dermatology (ABD), to present on Maintenance of Certification (MOC) CertLink in January at ODAC Dermatology, Aesthetic and Surgical conference.

Changes to MOC

A major shift in continuing certification is coming for board-certified dermatologists in January. Erik J. Stratman, MD will present, “Changes to Your MOC Requirements: What Every Dermatologist Should Know about CertLink,” on January 17th, 2020 at the J.W. Marriot in Orlando, Florida.

Workshop Description

Dr. Stratman will walk-through the CertLink® MOC program and demonstrate its design, rationale and navigation. According to the ABD, CertLink provides the utmost flexibility in MOC and provides an alternative to the one-time, sit-down, high stakes in-person MOC examination. Dermatologists will be able to go online and take test questions in the convenience of their own home or office at various times throughout the year.

ABD MOC CertLink®

CertLink® is a longitudinal testing platform. The platform is designed to test and build medical knowledge in a “test to competence” type model.  In addition, CertLink® will keep dermatologists up to date by providing the latest articles from dermatology subspecialties. CertLink™ assessment platform is powered by American Board of Medical Specialties (ABMS).

Registration and Fees

The pre-conference workshop is provided complimentary for dermatologists registered for ODAC 2020.

About ODAC

Attend ODAC to stay connected, informed, and up-to-date in dermatology. ODAC (previously Orlando Derm) is one of the largest and most prestigious conferences of the year. ODAC attracts a national audience of over 650 US Dermatology Physicians, Dermatology Residents, Nurse Practitioners and Physician Assistants.

Visit orlandoderm.org to register for ODAC and attend this workshop.  ODAC is a product of SanovaWorks.

 

 

ODAC Dermatology Sold Out Hot Topics

ODAC OFFERS MORE ACCESS TO HOT TOPICS

By | ODAC, Press

New York (Oct. 28, 2019) – The ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) is extending its program for 2020 with additional time for ODAC hot topics, general sessions and workshops.

Attendee Feedback

“We’ve listened to our attendees and altered our program to provide greater access to the hottest topics in the field,” said Perry Robins, MD, dermatologist and founder of ODAC. “Our sessions are led by expert faculty who provide the latest research and clinical updates on a variety of medical, surgical and aesthetic dermatology topics.”

The 2020 conference will be held January 17-20 at the JW Marriott in Orlando, Florida. ODAC, which started in 2003, attracts more than 650 dermatology physicians, residents, nurse practitioners and physician assistants each year.

The 2020 conference focuses on clinical dermatology updates, new treatments, new uses for old treatments, new product lines, changes to therapeutic guidelines, and hot and controversial topics. The interactive learning experience includes more than 20 workshops and more than 5 hours of live aesthetic demonstrations. In addition, ODAC offers hands-on sessions, live Q&As and opportunities to dialogue with leaders in the field. Up to 31 AMA PRA Category 1 Credits™ are available.

One-of-a-Kind

“There is no other conference like ODAC,” said dermatologist and conference chair James Spencer, MD, MS. “Each presentation provides practical pearls you can implement in your practice. This will be my 17th ODAC, and this meeting keeps getting better and better.”

In addition, three pre-conference workshops are available the first day of the conference:

  • “Comprehensive Nonsurgical Aesthetic Rejuvenation” with Martin Braun, MD
  • “Maintenance of Certification Workshop (Self-Assessment Credit)” with Erik Stratman, MD
  • “Derm In-Review Board Review” with session chair and conference medical director Adam Friedman, MD (in partnership with George Washington University)

Additional Faculty

  • Joel L. Cohen, MD, vice conference chair
  • Susan H. Weinkle, MD, vice conference chair
  • Martin Braun, MD
  • Justin Finch, MD
  • Robert Gotkin, MD
  • Jeremy Green, MD
  • William Hanke, MD
  • John Harris, MD
  • Sima Jain, MD
  • Terrence Keaney, MD
  • Leon Kircik, MD
  • Yasmine Kirkorian, MD
  • Sailesh Konda, MD
  • Angelo Landriscina, MD
  • Kavita Mariwalla, MD
  • Amy McMichael, MD
  • Alan Menter, MD
  • David Miller, MD
  • Vishal Patel, MD
  • Desiree Ratner, MD
  • Victor Ross, MD
  • Deborah S. Sarnoff, MD
  • Linda Stein Gold, MD
  • Erik Stratman, MD
  • Jackie Yee, MD
  • Jonathan Zippin, MD

Attendees may visit the exhibit hall that showcases the latest innovations in dermatology by more than 70 companies. In addition, more than 80 research and case study posters are available for viewing. The Advanced Resident Training and Education (ARTE) scholarship program provides the ODAC learning experience to more than 100 future dermatologists.

ODAC is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the Skin of Color Update conference.

Registration is available at orlandoderm.org.

DERMATOLOGY RESIDENT SCHOLARSHIPS FOR ODAC 2020

By | ODAC, Residents

ORLANDO (updated Oct.16, 2019) ODAC Dermatology, Aesthetic and Surgical (ODAC) conference announced the first round of dermatology resident scholarships for the January 17 – 20, 2020 meeting at the JW Marriott, Orlando, Florida.

ODAC has awarded over 3,000 dermatology resident scholarships over 16 years, and is hailed the #1 and largest scholarship program for dermatology meetings.

Residents enjoying the Resident Networking Reception at ODAC 2018

Each year, nearly 900 dermatologists and allied health professionals attend ODAC making it one of the largest medical, aesthetic and surgical dermatology conferences in the United States.  Of the 900 attendees, ODAC hosts over 150 US dermatology residents as part of the Advanced Resident Training Education (ARTE) Scholarship program.

Dermatology residents attending ODAC have the opportunity to be paired one-on-one with a mentor, publish with media partners, and present an abstract in the Annual ARTE Scholar Poster Session.  ODAC offers content specifically designed for the dermatologist-in-training including:

  • Dermatology In-Review Board Review Session hosted in conjunction with George Washington University
  • Resident Program Track with specific talks and workshops of most relevance for the resident attendee
  • 17th Annual Hands-On Aesthetic Training Workshop
  • 10th Annual Resident ARTE Scholar Poster Competition
  • Pair one-on-one with an expert mentor in the dermatology field
  • Publish in Next Steps in Derm
  • Network with your peers, our favorite part

Residents enjoying the Resident Networking Reception at ODAC 2018

From July to October 18th, ODAC accepts over 500 scholarship applications from dermatology residents training at over 160 US Dermatology Residency programs for MD and DO.  Resident applicants submit their C.V., a letter of good standing for their residency and compete with other program residents for the coveted scholarship positions.

On behalf of SanovaWorks,  we would like to congrats the first and second round of ARTE Scholar Awardees.

There is still time to apply! ODAC is accepting applications until October 18, 2019.  Apply now.

 

About ODAC

ODAC is the premier clinical dermatology conference expertly curated to provide comprehensive, annual updates and fresh pearls in medical, aesthetic and surgical dermatology.  The ODAC dermatology conference focuses on new uses for old treatments, incorporating new treatments, products and treatment lines, critical updates in diagnosis guidelines, as well as advanced techniques for enhancing your surgical and nonsurgical patient outcomes.